Global Biosimilars Forum

Global Biosimilars Forum

05-06-2014 - 06-06-2014 Vienna, Austria

The Global Biosimilars Forum consists of world-class keynote addresses, industry and academic presentations, case studies from leading pharmaceutical companies and panel debates, creating an interactive platform for high-level scientific and business discussion.

The Global Biosimilars Forum consists of world-class keynote addresses, industry and academic presentations, case studies from leading pharmaceutical companies and panel debates, creating an interactive platform for high-level scientific and business discussion.

Over two days, this event will attract senior-level decision makers working in biosimilars from around the world and will show the unique scientific and technical skill set required to face the challenges in the manufacture and development of biosimilar drugs.

There are practical challenges that face those manufacturing and developing biosimilars. It is crucial to understand the specific regulatory, development and clinical environment to help develop scientific process in taking biosimilars to the market.

The conference program consists of world-class keynote addresses, industry and academic presentations, case studies from leading pharmaceutical companies and panel debates, creating an interactive platform for high-level scientific and business discussion.

Why Attend

  • Understand the scientific authority behind the evolution of biosimilars
  • Get insight into changeable regulatory environment
  • Diagnosing the most excellence methods for grabbing a biosimilar from bench to market
  • Learn about flexible and cost effective manufacture of high quality biosimilars
  • Discover what are the market opportunities and commercial possibilities
  • Master biosimilar manufacture, process development
  • Hear about new tools and techniques for immunogenicity in development and the clinic
  • Understand the latest best practices in clinical trial design and execution
  • Developing prosperous and competitive biosimilars
  • Learn about pricing of biosimilars
  • Changing good science into a better authorization process and expanded patient access

Who Should Attend?

Senior VPs, Directors, & Managers with the following responsibilites:

  • Biosimilars
  • Biobetters
  • Biological Safety
  • Follow On Biologics
  • Cell Line Development
  • Protein Characterisation
  • Regulatory CMC
  • Clinical Trial Design
  • Commercial Biologics

Parexel

Parexel

Back to top